Edition:
United Kingdom

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,147JPY
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
¥2,147
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
136,689
52-wk High
¥2,197
52-wk Low
¥1,621

Chart for

About

ZERIA PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company operates in three business segments. The Ethical Pharmaceutical segment is principally involved in the manufacture, purchase and sale of ethical pharmaceutical products. The Consumer Healthcare segment is involved in the manufacture, purchase and... (more)

Overall

Beta: 0.43
Market Cap(Mil.): ¥106,663.30
Shares Outstanding(Mil.): 53.12
Dividend: 17.00
Yield (%): 1.59

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

BRIEF-Zeria Pharmaceutical says extension of share repurchase period

* Says it extends share repurchase period to a deadline of Feb. 6, 2018, instead of Nov. 2 previously

02 Nov 2017

BRIEF-Zeria Pharmaceutical to repurchase 6.8 pct shares

* Says it plans to repurchase up to 3.6 million shares, representing 6.8 percent of outstanding

04 Aug 2017

BRIEF-Zeria Pharmaceutical ends license agreement with EA Pharma

* Says it ends a license agreement with EA Pharma Co Ltd, regarding proton pump inhibitor E3710

16 Jun 2017

BRIEF-Zeria Pharmaceutical to repurchase 3.4 pct shares

* Says it will repurchase up to 1.8 million shares, representing 3.4 percent of outstanding

16 Jun 2017

Earnings vs. Estimates